Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
LeukoStrat CDx FLT3 Mutation Assay Laboratory for Personalized Molecular Medicine United States | 1 | 1 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
Congenital Neutropenia GenePanel Mayo Clinic Laboratories Mayo Clinic United States | 46 | 30 |
|
EBV/Lymphoproliferation GenePanel Mayo Clinic Laboratories Mayo Clinic United States | 35 | 25 |
|
Bone marrow culture for cancer Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 4 | 24 |
|
FLT3 ITD & TKD Mutation detection by PCR Laboratory for Personalized Molecular Medicine United States | 1 | 1 |
|
Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 2 | 73 |
|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 1 | 52 |
|
Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 |
|
UCSF Molecular Diagnostics Laboratory UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 4 | 52 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
ETV6 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
GATA2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
KIT - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
RUNX1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Multi-Cancer + RNA Panel Invitae United States | 143 | 63 |
|
Invitae Common Hereditary Cancers + RNA Panel Invitae United States | 114 | 47 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.